Text Size

Measurement of Cancer-Related Risk Perception in Smokers

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Adelphi University
Queen's Hospital Center
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00588211
First received: December 24, 2007
Last updated: November 20, 2012
Last verified: November 2012
History of Changes
  Purpose

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.


Condition Intervention
Cancer Related-Risks
Risk Perception
Survey
Focus Group
 Behavioral: Interviews
Behavioral: focus group
Behavioral: Survey

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Measurement of Cancer-Related Risk Perception in Smokers

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • to establish initial evidence for scale reliability and validity [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Enrollment: 1514
Study Start Date: September 2001
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use.
 Behavioral: Interviews
45-minute individual interviews after the conclusion of their dental appointment
2
Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room.
 Behavioral: focus group
A focus group of the preliminary cancer-related risk perception item pool.
3
Third, we will survey 200 student participants from Adelphi University.
 Behavioral: Survey
Quantitative item analysis of the final item pool.
4
Queens Hospital Center with 800 patients.
 Behavioral: Survey
A second confirmatory factor analysis.

Detailed Description:

The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
  • clinic patients Queens Hospital Center
  • students participants from Adelphi University
Criteria

Inclusion Criteria:

  • Subject must be >= to 18 years of age
  • For recruitment at Adelphi University: Speak English
  • For recruitment at Queens Hospital Center: Speak English
  • For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient

Exclusion Criteria:

  • Patients who have a history of colorectal cancer at the Queens Hospital Center
  • Patients who cannot give informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00588211

Locations
United States, New York
Queens Hospital Center
Jamaica, New York, United States, 11432
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Adelphi University
New York, New York, United States, 11013
New York University, College of Dentistry
New York, New York, United States, 10010
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Adelphi University
Queen's Hospital Center
Investigators
Principal Investigator: Jennifer L Hay, PhD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
Memorial Sloan-Kettering web site  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00588211     History of Changes
Other Study ID Numbers: 01-121, CA93182
Study First Received: December 24, 2007
Last Updated: November 20, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Cancer related-Risks
Risk Perception
Survey
 Focus Group
Smoking cessation
tobacco

ClinicalTrials.gov processed this record on May 21, 2013